Your session is about to expire
← Back to Search
Biologic
BLVR Treatment for Emphysema
Phase 2
Waitlist Available
Led By Mark Gotfried, MD
Research Sponsored by Aeris Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
Evaluate the efficacy and safety of the 10 mL BLVR System in 1 or 2 treatment sessions (8 subsegments, 4 in each lung) in patients with advanced upper lobe predominant emphysema.
Eligible Conditions
- Emphysema
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: BLVR TreatmentExperimental Treatment1 Intervention
BLVR Treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BLVR Treatment
2007
Completed Phase 2
~20
Find a Location
Who is running the clinical trial?
Aeris TherapeuticsLead Sponsor
17 Previous Clinical Trials
914 Total Patients Enrolled
17 Trials studying Emphysema
914 Patients Enrolled for Emphysema
Mark Gotfried, MDPrincipal InvestigatorPulmonary Associates
3 Previous Clinical Trials
81 Total Patients Enrolled
2 Trials studying Emphysema
55 Patients Enrolled for Emphysema
Charlie Strange, MDPrincipal InvestigatorMedical Univ South Carolina Hospital
7 Previous Clinical Trials
819 Total Patients Enrolled
4 Trials studying Emphysema
484 Patients Enrolled for Emphysema
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger